XML 57 R30.htm IDEA: XBRL DOCUMENT v3.25.4
Net Loss per Share
 12 Months Ended
Dec. 31, 2025
Earnings Per Share [Abstract]  
Net Loss per Share Net Loss per Share
The calculation of earnings per common share is as follows (in thousands, except share data):
Year Ended December 31,
202520242023
Numerator:
Net loss$(312,763)$(547,029)$(892,869)
Denominator
Weighted average common shares outstanding55,457,67651,894,63948,610,507
Net loss per share$(5.64)$(10.54)$(18.37)
The following potential common shares, presented based on amounts outstanding at each period end, were excluded from the calculation of diluted net loss per share attributable to Ginkgo Bioworks Holdings, Inc. common stockholders for the periods presented because including them would have been anti-dilutive:
As of December 31,
202520242023
Unvested PSUs4,407,287— — 
Warrants to purchase Class A common stock1,295,6221,295,6221,295,622
Unvested RSUs1,262,8533,327,3983,804,189
Earnout shares (1)
3,793,0633,794,2433,803,049
Outstanding stock options366,567767,520192,208
Escrow shares (2)
— 20,332 — 
11,125,3929,205,1159,095,068
(1)Represents employee and non-employee earnout shares for which the service-based and/or market-based vesting conditions have not been satisfied.
(2)Represents restricted common stock issued in connection with asset acquisitions, held in escrow for indemnification purposes, and subject to forfeiture.